The China Cardiac Biomarkers Market is seeing rapid expansion in clinical utilization as healthcare systems integrate biomarker-based diagnostics into routine and emergency cardiac workflows. Cardiovascular disease is a leading cause of morbidity in China, creating a strong need for fast and accurate diagnostic tools. Troponins, CK-MB, BNP, myoglobin, and emerging markers are used not only for...
English 
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt